Literature DB >> 23835048

To dream the impossible dream: universal influenza vaccination.

Jonathan W Yewdell1.   

Abstract

Year in and year out, influenza viruses exact a deadly and expensive toll on humanity. Current vaccines simply do not keep pace with viral immune evasion, providing partial protection, at best, among various age groups. A quantum leap in understanding the basic principles of the adaptive and innate immune responses to influenza viruses offers the opportunity to develop vaccines that forestall, and potentially ultimately defeat, influenza virus antigenic variation. Published by Elsevier B.V.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23835048      PMCID： PMC3713083          DOI： 10.1016/j.coviro.2013.05.008

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN： 1879-6257            Impact factor:   7.090


  57 in total

Review 1.  Influenza vaccines: T-cell responses deserve more attention.

Authors:  Michael Schotsaert; Xavier Saelens; Geert Leroux-Roels
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

2.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

Authors:  Davide Corti; Amorsolo L Suguitan; Debora Pinna; Chiara Silacci; Blanca M Fernandez-Rodriguez; Fabrizia Vanzetta; Celia Santos; Catherine J Luke; Fernando J Torres-Velez; Nigel J Temperton; Robin A Weiss; Federica Sallusto; Kanta Subbarao; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

3.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

4.  A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

6.  Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies.

Authors:  W Gerhard; J Yewdell; M E Frankel; R Webster
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

7.  H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.

Authors:  Irina Margine; Rong Hai; Randy A Albrecht; Gerlinde Obermoser; A Carson Harrod; Jacques Banchereau; Karolina Palucka; Adolfo García-Sastre; Peter Palese; John J Treanor; Florian Krammer
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

8.  Lineage structure of the human antibody repertoire in response to influenza vaccination.

Authors:  Ning Jiang; Jiankui He; Joshua A Weinstein; Lolita Penland; Sanae Sasaki; Xiao-Song He; Cornelia L Dekker; Nai-Ying Zheng; Min Huang; Meghan Sullivan; Patrick C Wilson; Harry B Greenberg; Mark M Davis; Daniel S Fisher; Stephen R Quake
Journal:  Sci Transl Med       Date:  2013-02-06       Impact factor: 17.956

9.  Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Authors:  Mark Throsby; Edward van den Brink; Mandy Jongeneelen; Leo L M Poon; Philippe Alard; Lisette Cornelissen; Arjen Bakker; Freek Cox; Els van Deventer; Yi Guan; Jindrich Cinatl; Jan ter Meulen; Ignace Lasters; Rita Carsetti; Malik Peiris; John de Kruif; Jaap Goudsmit
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

10.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice.

Authors:  L M Staudt; W Gerhard
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307
View more
  14 in total

1.  Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

Authors:  Matthew J Memoli; Lindsay Czajkowski; Susan Reed; Rani Athota; Tyler Bristol; Kathleen Proudfoot; Sarah Fargis; Matthew Stein; Rebecca L Dunfee; Pamela A Shaw; Richard T Davey; Jeffery K Taubenberger
Journal:  Clin Infect Dis       Date:  2014-11-20       Impact factor: 9.079

Review 2.  Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.

Authors:  R Servín-Blanco; R Zamora-Alvarado; G Gevorkian; K Manoutcharian
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

3.  Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets.

Authors:  Raffael Nachbagauer; Matthew S Miller; Rong Hai; Alex B Ryder; John K Rose; Peter Palese; Adolfo García-Sastre; Florian Krammer; Randy A Albrecht
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 4.  Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.

Authors:  Scott E Hensley
Journal:  Curr Opin Virol       Date:  2014-08-11       Impact factor: 7.090

5.  An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.

Authors:  Louis M Schwartzman; Andrea L Cathcart; Lindsey M Pujanauski; Li Qi; John C Kash; Jeffery K Taubenberger
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

6.  Contemporary avian influenza A virus subtype H1, H6, H7, H10, and H15 hemagglutinin genes encode a mammalian virulence factor similar to the 1918 pandemic virus H1 hemagglutinin.

Authors:  Li Qi; Lindsey M Pujanauski; A Sally Davis; Louis M Schwartzman; Daniel S Chertow; David Baxter; Kelsey Scherler; Kevan L Hartshorn; Richard D Slemons; Kathie-Anne Walters; John C Kash; Jeffery K Taubenberger
Journal:  mBio       Date:  2014-11-18       Impact factor: 7.867

7.  A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells.

Authors:  Venkateswara R Simhadri; Milena Dimitrova; John L Mariano; Olatz Zenarruzabeitia; Weimin Zhong; Tatsuhiko Ozawa; Atsushi Muraguchi; Hiroyuki Kishi; Maryna C Eichelberger; Francisco Borrego
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

8.  Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.

Authors:  Javier G Magadán; Meghan O Altman; William L Ince; Heather D Hickman; James Stevens; Aaron Chevalier; David Baker; Patrick C Wilson; Rafi Ahmed; Jack R Bennink; Jonathan W Yewdell
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

9.  Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes.

Authors:  Nicole L Kallewaard; Davide Corti; Patrick J Collins; Ursula Neu; Josephine M McAuliffe; Ebony Benjamin; Leslie Wachter-Rosati; Frances J Palmer-Hill; Andy Q Yuan; Philip A Walker; Matthias K Vorlaender; Siro Bianchi; Barbara Guarino; Anna De Marco; Fabrizia Vanzetta; Gloria Agatic; Mathilde Foglierini; Debora Pinna; Blanca Fernandez-Rodriguez; Alexander Fruehwirth; Chiara Silacci; Roksana W Ogrodowicz; Stephen R Martin; Federica Sallusto; JoAnn A Suzich; Antonio Lanzavecchia; Qing Zhu; Steven J Gamblin; John J Skehel
Journal:  Cell       Date:  2016-07-21       Impact factor: 41.582

10.  Is it possible? A different approach to creating a universal influenza vaccine.

Authors:  Stacey Schultz-Cherry
Journal:  mBio       Date:  2015-10-06       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.